Enzo Biochem, Inc.
ENZB
$0.4899
-$0.0001-0.02%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.33M | 6.21M | 7.53M | 8.02M | 8.55M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.33M | 6.21M | 7.53M | 8.02M | 8.55M |
| Cost of Revenue | 3.55M | 3.93M | 4.31M | 4.29M | 4.33M |
| Gross Profit | 3.79M | 2.28M | 3.22M | 3.73M | 4.22M |
| SG&A Expenses | 4.91M | 5.34M | 5.28M | 5.17M | 5.83M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.94M | 9.84M | 10.19M | 10.07M | 10.74M |
| Operating Income | -1.60M | -3.62M | -2.67M | -2.04M | -2.19M |
| Income Before Tax | -1.25M | -3.07M | -1.15M | -2.13M | -863.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.25M | -3.07M | -1.15M | -2.13M | -863.00K |
| Earnings from Discontinued Operations | -287.00K | -305.00K | -12.23M | -889.00K | -2.20M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.54M | -3.38M | -13.38M | -3.02M | -3.06M |
| EBIT | -1.60M | -3.62M | -2.67M | -2.04M | -2.19M |
| EBITDA | -1.28M | -3.30M | -2.27M | -1.71M | -1.92M |
| EPS Basic | -0.03 | -0.06 | -0.26 | -0.06 | -0.06 |
| Normalized Basic EPS | -0.01 | -0.04 | -0.01 | -0.03 | -0.01 |
| EPS Diluted | -0.03 | -0.07 | -0.26 | -0.06 | -0.06 |
| Normalized Diluted EPS | -0.01 | -0.04 | -0.01 | -0.03 | -0.01 |
| Average Basic Shares Outstanding | 52.30M | 52.24M | 50.90M | 51.21M | 50.49M |
| Average Diluted Shares Outstanding | 52.30M | 52.24M | 50.90M | 51.21M | 50.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -346.84% | -- | -- | -- | -- |